ARTICLE | Clinical News
BA058-transdermal: Completed Phase II enrollment
January 14, 2013 8:00 AM UTC
Radius completed enrollment of 250 postmenopausal women with osteoporosis in a double-blind, placebo-controlled, international Phase II trial comparing 50, 100 and 150 µg BA058-TD once daily vs. once-...